Results 111 to 120 of about 3,066 (203)

Gonadotropin-Releasing Hormone Receptor Antagonist Mono- and Combination Therapy With Estradiol/Norethindrone Acetate Add-Back: Pharmacodynamics and Safety of OBE2109

open access: yes, 2017
Context OBE2109 is a potent, oral gonadotropin-releasing hormone receptor antagonist being developed for the treatment of sex-hormone–dependent diseases in women. Objective
Line Marchand   +4 more
core   +1 more source

Norethindrone acetate versus extended-cycle oral contraceptive (Seasonique ® ) in the treatment of endometriosis symptoms: A prospective open-label comparative study

open access: yes, 2018
Introduction: This patient preference prospective study was designed to compare patients' satisfaction in women with endometriosis treated either by an extended-cycle oral contraception (OC) or by norethindrone acetate (NETA).
F. Barra   +9 more
core   +1 more source

Impact of demographic and clinical factors on elagolix plus add-back therapy effects on patient-reported nonbleeding symptoms in women with heavy menstrual bleeding and uterine fibroids: a post hoc analysis of data from two clinical trials

open access: yesF&S Reports
Objective: To investigate the efficacy of elagolix plus add-back therapy (estradiol [1 mg] and norethindrone acetate [0.5 mg] once daily) on patient-reported nonbleeding symptoms and menstrual bleeding associated with uterine fibroids (UFs) across ...
James A. Simon, M.D.   +4 more
doaj   +1 more source

Norethindrone acetate versus dienogest for pain relief in endometriosis related pain: A randomized controlled trial

open access: yes
Objective: To determine which progestin, norethindrone acetate (NETA) or dienogest, is more effective in alleviating pain associated with endometriosis? Study design: This single-center, prospective, randomized trial included 70 patients aged 18-40 years
Aslan, Kiper   +4 more
core   +1 more source

Effect of Protease Inhibitors on Steady-State Pharmacokinetics of Oral Norethindrone Contraception in HIV-Infected Women

open access: yes
OBJECTIVE: Pharmacokinetic interactions exist between combined oral contraceptives and protease inhibitors (PI). However, such information is lacking for progestin-only oral contraception.
Kovacs, Andrea   +5 more
core  

Comparison of Dermatologic and Neuropsychological Side Effects of Oral Contraceptives, 2016-2020. [PDF]

open access: yesOpen Access J Contracept
Visingardi J   +3 more
europepmc   +1 more source

The effect of female reproductive hormones on the perception of cuteness

open access: yes, 2012
The findings of two recent studies suggest that cuteness sensitivity may be modulated by the female reproductive hormones estrogen and progesterone, with women showing greater sensitivity than men (Sprengelmeyer et al 2009; Lobmaier et al 2010) and women
Lewis, Jennifer
core  

Home - About - Disclaimer - Privacy